Home/Filings/3/0000950170-24-106088
3//SEC Filing

New Enterprise Associates 17, L.P. 3

Accession 0000950170-24-106088

CIK 0001776111other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 7:19 PM ET

Size

9.7 KB

Accession

0000950170-24-106088

Insider Transaction Report

Form 3
Period: 2024-09-12
Holdings
  • Series A Convertible Preferred Stock

    Common Stock (1,023,103 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (2,091,383 underlying)
Holdings
  • Series A Convertible Preferred Stock

    Common Stock (1,023,103 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (2,091,383 underlying)
Holdings
  • Series A Convertible Preferred Stock

    Common Stock (1,023,103 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (2,091,383 underlying)
Footnotes (2)
  • [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into Common Stock on a one-for-12.0221 basis at any time at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
  • [F2]The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.

Documents

1 file

Issuer

MBX Biosciences, Inc.

CIK 0001776111

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001768564

Filing Metadata

Form type
3
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 7:19 PM ET
Size
9.7 KB